Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Next Generation Sequencing Asia 2016: Clinical Applications

John Leite's Biography



John Leite, Vice President, Product Marketing and Market Development, Oncology, Illumina

John is the Vice President of Oncology, Market Development & Product Marketing for Illumina’s Oncology Business Unit. Prior to joining Illumina, John was Vice President of Commercial Strategy and Market Access for Genoptix Inc., a Novartis company where, from 2008 until 2014, he drove several functions including Marketing and Business Development, building the portfolio of oncology diagnostic services. John began his career as a scientist for Invitrogen (now Thermo Fisher Scientific) before transitioning to the business team as a marketer overseeing product management of the proteomics portfolio. He earned his Ph.D. in Molecular Genetics & Biochemistry from the University of Pittsburgh, School of Medicine in 2000, and was a National Research Service Award Scholar at the California Institute of Technology from 2000 to 2003.

John Leite Image

Lowering the Clinical Adoption Barriers of Next-Generation Sequencing

Thursday, 1 December 2016 at 09:00

Add to Calendar ▼2016-12-01 09:00:002016-12-01 10:00:00Europe/LondonLowering the Clinical Adoption Barriers of Next-Generation SequencingNext Generation Sequencing Asia 2016: Clinical Applications in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com

Next-generation sequencing has demonstrated tremendous promise in significantly improving outcomes for a number of diseases and improving overall health. We will explore the remaining challenges associated with driving this technology to be a part of standard of care.


Add to Calendar ▼2016-12-01 00:00:002016-12-02 00:00:00Europe/LondonNext Generation Sequencing Asia 2016: Clinical ApplicationsNext Generation Sequencing Asia 2016: Clinical Applications in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com